Natco Pharma submits press release

26 Feb 2021 Evaluate

Natco Pharma has informed that it enclosed press release on February 26th 2021, titled ‘Natco launches Brivaracetam tablets, in India, for treatment of epilepsy’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

886.80 -16.75 (-1.85%)
01-Jan-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1250.85
Cipla 1499.55
Zydus Lifesciences 912.55
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×